LTFS
AVNR

Ladenburg Thalmann Financial Services’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio AVNR Stock Details AVNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,000
Closed -$34K – 4818
2014
Q4 		$34K Sell
2,000
-8,000
-80% -$113K ﹤0.01% 2626
2014
Q3 		$119K Sell
10,000
-6,000
-38% -$41K ﹤0.01% 1508
2014
Q2 		$90K Buy
16,000
+1,000
+7% +$4.61K ﹤0.01% 1678
2014
Q1 		$55K Hold
15,000
– – ﹤0.01% 1898
2013
Q4 		$50K Hold
15,000
– – ﹤0.01% 1927
2013
Q3 		$63K Hold
15,000
– – ﹤0.01% 1672
2013
Q2 		$69K Buy
+15,000
New +$51.6K ﹤0.01% 1517

Ladenburg Thalmann Financial Services's AVNR Position: Q1 2015 in Review

Ladenburg Thalmann Financial Services sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 2,000 shares — an estimated $34K sold.

Ladenburg Thalmann Financial Services first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $119K in Q3 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Ladenburg Thalmann Financial Services reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 2,000 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $34K.
  • Ladenburg Thalmann Financial Services first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
  • Ladenburg Thalmann Financial Services's AVANIR PHARMACEUTICALS, INC CL A position peaked at $119K in Q3 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q1 2015, filed 15 May 2015.